In 2013, a team of four medical researchers lead by Dr. Elizabeth Penner MD, MPH, carried out a clinical study with over 4,500 participants, called “The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults”. They concluded: “We found that marijuana use was associated with lower levels of fasting insulin and HOMA-IR, and smaller waist circumference.”
Frankel runs GreenBridge Medical, which he founded in 2006, like an internist’s office. He begins with a one-hour consult, comes up with a treatment plan, and recommends products for which he designed the formulas: ten oils with different combinations of THC and CBD. (THC gets you high; CBD doesn’t, but is alleged to have strong healing properties) The #1 oil is almost all CBD, #10 is almost all THC, and #5 has equal amounts of both. So the doctor, patient, and dispensary know how many milligrams of what chemicals the patient is taking, and the doctor can adjust the dose as needed.
Another marker of obesity and diabetes includes damage to liver cells. The liver is a major organ in the conversion between stored energy forms and useable energy forms in the body. Overburdening that system, such as with high fructose intake, can have disastrous effects. Inflammation within the liver indicates the onset of dysfunction, and possibly non-alcoholic fatty liver disease.
When the endocannabinoid system becomes dysregulated, it often becomes overactive and too much fat is being stored, particularly in the intra-abdominal tissue. Cannabidiol is known to regulate the endocannabinoid system as it can restore balance in both directions. Therefore, the study concludes that, along with lifestyle changes cannabis could be a means of fighting obesity.